SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-21-135345
Filing Date
2021-04-28
Accepted
2021-04-28 07:03:53
Documents
10
Period of Report
2021-06-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A d59948ddef14a.htm DEF 14A 324840
2 GRAPHIC g59948dsp002.jpg GRAPHIC 7936
3 GRAPHIC g59948g07j31.jpg GRAPHIC 1087
4 GRAPHIC g59948g13o68.jpg GRAPHIC 944
5 GRAPHIC g59948g26f65.jpg GRAPHIC 1362
6 GRAPHIC g59948g46v66.jpg GRAPHIC 861
7 GRAPHIC g59948g61q95.jpg GRAPHIC 952
8 GRAPHIC g59948g67c36.jpg GRAPHIC 1677
9 GRAPHIC g59948g75q85.jpg GRAPHIC 1862
10 GRAPHIC g59948g89p52.jpg GRAPHIC 1045
  Complete submission text file 0001193125-21-135345.txt   351600
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37783 | Film No.: 21861288
SIC: 2834 Pharmaceutical Preparations